Kashif Jilani Selected Research

Fluo-3

5/2014	In vitro induction of erythrocyte phosphatidylserine translocation by the natural naphthoquinone shikonin.
7/2013	Fluoxetine induced suicidal erythrocyte death.
11/2012	Enhanced Ca2+ entry, ceramide formation, and apoptotic death of erythrocytes triggered by plumbagin.
1/2012	Induction of programmed erythrocyte death by gambogic acid.
1/2012	Enhanced erythrocyte membrane exposure of phosphatidylserine following sorafenib treatment: an in vivo and in vitro study.
1/2012	Sulindac sulfide--induced stimulation of eryptosis.
10/2011	Triggering of erythrocyte cell membrane scrambling by ursolic acid.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kashif Jilani Research Topics

Disease

31	Hemolysis 04/2022 - 01/2011
18	Neoplasms (Cancer) 06/2015 - 07/2011
6	Anemia 07/2020 - 01/2011
2	Shock 01/2015 - 01/2011
2	Balkan Nephropathy (Balkan Endemic Nephropathy) 01/2014 - 01/2012
1	Rheumatoid Arthritis 01/2020
1	Osteoarthritis 01/2020
1	Hypercholesterolemia 07/2019
1	Carcinoma (Carcinomatosis) 01/2014
1	Hypoxia (Hypoxemia) 01/2014
1	Acute Kidney Injury (Acute Renal Failure) 01/2014
1	Parkinson Disease (Parkinson's Disease) 10/2012
1	Carcinogenesis 04/2012
1	Inflammation (Inflammations) 04/2012
1	Hepatocellular Carcinoma (Hepatoma) 01/2012
1	Mitochondrial Diseases (Mitochondrial Disease) 09/2011
1	Wounds and Injuries (Trauma) 01/2011
1	Hemorrhage 01/2011

Drug/Important Bio-Agent (IBA)

27	Annexin A5IBA 11/2014 - 01/2011
24	PhosphatidylserinesIBA 11/2014 - 01/2011
23	Hemoglobins (Hemoglobin)IBA 05/2014 - 01/2011
18	CeramidesIBA 05/2014 - 01/2011
16	AntibodiesIBA 05/2014 - 01/2011
8	Adenosine Triphosphate (ATP)IBA 04/2012 - 07/2011
8	LuciferasesIBA 04/2012 - 07/2011
7	Fluo-3IBA 05/2014 - 10/2011
6	LuciferinsIBA 04/2012 - 07/2011
4	Pharmaceutical PreparationsIBA 01/2020 - 01/2011
4	Anti-Bacterial Agents (Antibiotics)IBA 11/2014 - 09/2011
4	Phospholipids (Phosphatides)FDA LinkGeneric 11/2012 - 01/2011
3	diacetyldichlorofluoresceinIBA 11/2014 - 01/2012
2	CatalaseIBA 07/2020 - 01/2020
2	Superoxide DismutaseIBA 07/2020 - 01/2020
2	Glutathione PeroxidaseIBA 07/2020 - 01/2020
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2020 - 01/2012
2	quinone (benzoquinone)IBA 06/2015 - 01/2013
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2014 - 01/2014
2	TriterpenesIBA 02/2013 - 10/2011
2	MycotoxinsIBA 01/2013 - 01/2012
2	Phosphotransferases (Kinase)IBA 01/2012 - 01/2011
2	Antineoplastic Agents (Antineoplastics)IBA 01/2012 - 07/2011
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2012 - 01/2011
1	Methotrexate (Mexate)FDA LinkGeneric 04/2022
1	bifenthrinIBA 01/2022
1	Omeprazole (Prilosec)FDA LinkGeneric 07/2020
1	Naproxen (Naprosyn)FDA LinkGeneric 01/2020
1	AntipyreticsIBA 01/2020
1	Analgesics (Analgesic Drugs)IBA 01/2020
1	Oxidoreductases (Dehydrogenase)IBA 07/2019
1	Atorvastatin (Lipitor)FDA Link 07/2019
1	jugloneIBA 06/2015
1	Sucrose (Saccharose)IBA 01/2015
1	Vitamin D FDA LinkGeneric 01/2015
1	Glucose (Dextrose)FDA LinkGeneric 01/2015
1	IonophoresIBA 11/2014
1	salinomycinIBA 11/2014
1	piperlongumineIBA 10/2014
1	baicaleinIBA 09/2014
1	FlavonoidsIBA 09/2014
1	geduninIBA 01/2014
1	Novobiocin (Streptonivicin)FDA Link 01/2014
1	cryptotanshinoneIBA 01/2014
1	aristolochic acid I (aristolochic acid)IBA 01/2014
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2013
1	Celecoxib (Celebrex)FDA Link 09/2013
1	honokiolIBA 09/2013
1	diphenyl (biphenyl)IBA 09/2013
1	CyclohexaneIBA 05/2013
1	fumagillinIBA 05/2013
1	Alkylating AgentsIBA 04/2013
1	Carmustine (FIVB)FDA Link 04/2013
1	withaferin AIBA 02/2013
1	Rifabutin (Ansamycin)FDA Link 01/2013
1	geldanamycinIBA 01/2013
1	PatulinIBA 01/2013
1	tricarbonyldichlororuthenium (II) dimerIBA 11/2012
1	PesticidesIBA 10/2012
1	RotenoneIBA 10/2012
1	chromium hexavalent ionIBA 04/2012
1	ApigeninIBA 01/2012
1	tanshinoneIBA 01/2012
1	AntioxidantsIBA 01/2012
1	Sorafenib (BAY 43-9006)FDA Link 01/2012
1	gambogic acidIBA 01/2012
1	ochratoxin AIBA 01/2012
1	sulindac sulfideIBA 01/2012
1	polytyrosineIBA 01/2012
1	OchratoxinsIBA 01/2012
1	Ursolic AcidIBA 10/2011
1	enniatinsIBA 09/2011
1	Peptides (Polypeptides)IBA 09/2011
1	oridoninIBA 07/2011
1	Surface-Active Agents (Surfactants)IBA 01/2011
1	Dicumarol (Dicoumarol)FDA Link 01/2011
1	Benzethonium (Magic, Formula)IBA 01/2011
1	AnticoagulantsIBA 01/2011
1	CationsIBA 01/2011
1	Disinfectants (Biocides)IBA 01/2011
1	p38 Mitogen-Activated Protein KinasesIBA 01/2011

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2012